Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25,468 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea.
Mihreteab S, Platon L, Berhane A, Stokes BH, Warsame M, Campagne P, Criscuolo A, Ma L, Petiot N, Doderer-Lang C, Legrand E, Ward KE, Zehaie Kassahun A, Ringwald P, Fidock DA, Ménard D. Mihreteab S, et al. Among authors: ma l. N Engl J Med. 2023 Sep 28;389(13):1191-1202. doi: 10.1056/NEJMoa2210956. N Engl J Med. 2023. PMID: 37754284 Free PMC article.
Prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine before and after community delivery of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa: a multi-country evaluation.
Figueroa-Romero A, Bissombolo D, Meremikwu M, Ratsimbasoa A, Sacoor C, Arikpo I, Lemba E, Nhama A, Rakotosaona R, Llach M, Pons-Duran C, Sanz S, Ma L, Doderer-Lang C, Maly C, Roman E, Pagnoni F, Mayor A, Menard D, González R, Menéndez C. Figueroa-Romero A, et al. Among authors: ma l. Lancet Glob Health. 2023 Nov;11(11):e1765-e1774. doi: 10.1016/S2214-109X(23)00414-X. Lancet Glob Health. 2023. PMID: 37858587 Free article.
Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine and prevalence of molecular markers of anti-malarial drug resistance in children in Togo in 2021.
Dorkenoo AM, Warsame M, Ataba E, Hemou M, Yakpa K, Sossou E, Mitigmsagou M, Teou CD, Caspar E, Ma L, Djadou KE, Atcha-Oubou T, Rasmussen C, Menard D. Dorkenoo AM, et al. Among authors: ma l. Malar J. 2024 Apr 3;23(1):92. doi: 10.1186/s12936-024-04922-1. Malar J. 2024. PMID: 38570791 Free PMC article. Clinical Trial.
Dynamic Response of Ionic Current in Conical Nanopores.
Liu Z, Ma L, Zhang H, Zhuang J, Man J, Siwy ZS, Qiu Y. Liu Z, et al. Among authors: ma l. ACS Appl Mater Interfaces. 2024 Jun 3. doi: 10.1021/acsami.4c02078. Online ahead of print. ACS Appl Mater Interfaces. 2024. PMID: 38830306
Jinlida for Diabetes Prevention in Impaired Glucose Tolerance and Multiple Metabolic Abnormalities: The FOCUS Randomized Clinical Trial.
Ji H, Zhao X, Chen X, Fang H, Gao H, Wei G, Zhang M, Kuang H, Yang B, Cai X, Su Y, Piao C, Zhao S, Li L, Sun W, Xu T, Xu Q, Fan Y, Ye J, Yao C, Shang M, Song G, Chen L, Zheng Q, Xiao X, Yan L, Lian F, Tong X, Jia Z; FOCUS Trial Committees and Investigators. Ji H, et al. JAMA Intern Med. 2024 Jun 3. doi: 10.1001/jamainternmed.2024.1190. Online ahead of print. JAMA Intern Med. 2024. PMID: 38829648
25,468 results
You have reached the last available page of results. Please see the User Guide for more information.